Certain off-campus HOPDs subject to site-neutral payments: 4 key points

Beginning Jan. 1, 2017, provider-based, off-campus hospital outpatient departments will be subject to site-neutral payments, according to a JD Supra report. 

Advertisement

Here are four takeaways.

1. The site-neutral payment regulation, a provision of the Balanced Budget Act of 2015, will apply to provider-based, off-campus HOPDs established after Nov. 1, 2015.

2. After the site-neutral payment effective date, these HOPDs will be reimbursed under the Ambulatory Surgical Center Fee Schedule or Medicare Physician Fee Schedule, according to the report.

3. HOPDs established before Nov. 2, 2015 are considered grandfathered and will continue to receive reimbursement under the Medicare Hospital Outpatient Prospective Payment System.

4. This change in HOPD reimbursement could affect hospitals’ decision to pursue physician practice acquisitions, as physician services may not generate a higher income stream, according to the report.

More articles on coding and billing:
MedPAC proposes eliminating ASC payment updates in 2017: 5 key notes
5 key observations on ASC payer contracts in 2016
54 things to know about 6 major US payers

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Coding, Billing & Collections

Advertisement

Comments are closed.